The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity

References

• Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta 2004;1739:5–25.
   PubMed Web of Science ®Google Scholar
• Westermark P, Wernstedt C, Wilander E, Hayden DW, O'Brien TD, Johnson KH. Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. Proc Natl Acad Sci USA 1987;84:3881–3885.
   PubMed Web of Science ®Google Scholar
• Clark A, de Koning EJ, Hattersley AT, Hansen BC, Yajnik CS, Poulton J. Pancreatic pathology in non-insulin dependent diabetes (NIDDM). Diabetes Res Clin Pract 1995;28 (Suppl):S39–S47.
   PubMed Web of Science ®Google Scholar
• Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102–110.
   PubMed Web of Science ®Google Scholar
• Gepts W, Lecompte PM. The pancreatic islets in diabetes. Am J Med 1981;70:105–115.
   PubMed Web of Science ®Google Scholar
• Huang CJ, Haataja L, Gurlo T, et al. Induction of endoplasmic reticulum stress-induced β-cell apoptosis and accumulation of polyubiquitinated proteins by human islet amyloid polypeptide. Am J Physiol Endocrinol Metab 2007;293:E1656–E1662.
   PubMed Web of Science ®Google Scholar
• Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, Yoo SJ, Kang MI, Cha BY, Lee KW, et al. Selective β-cell loss and α-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab 2003;88:2300–2308.
   PubMed Web of Science ®Google Scholar
• Westermark P, Engstrom U, Johnson KH, Westermark GT, Betsholtz C. Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation. Proc Natl Acad Sci USA 1990;87:5036–5040.
   PubMed Web of Science ®Google Scholar
• Haataja L, Gurlo T, Huang CJ, Butler PC. Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. Endocr Rev 2008;29:303–316.
   PubMed Web of Science ®Google Scholar
• Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 2003;300:486–489.
   PubMed Web of Science ®Google Scholar
• Ammon HP WM. Pharmacology of Curcuma longa. Planta Med 1991;57:1–7.
   PubMed Web of Science ®Google Scholar
• Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res 2003;23:363–398.
   PubMed Web of Science ®Google Scholar
• Mazumder A RK, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol 1995;49:1165–1170.
   PubMed Web of Science ®Google Scholar
• Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, et al. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 2005;280:5892–5901.
   PubMed Web of Science ®Google Scholar
• Garcia-Alloza M, Borrelli LA, Rozkalne A, Hyman BT, Bacskai BJ. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J Neurochem 2007;102:1095–1104.
   PubMed Web of Science ®Google Scholar
• Pandey N, Strider J, Nolan WC, Yan SX, Galvin JE. Curcumin inhibits aggregation of α-synuclein. Acta Neuropathol 2008;115:479–489.
   PubMed Web of Science ®Google Scholar
• Hafner-Bratkovic I, Gaspersic J, Smid LM, Bresjanac M, Jerala R. Curcumin binds to the α-helical intermediate and to the amyloid form of prion protein – a new mechanism for the inhibition of PrP(Sc) accumulation. J Neurochem 2008;104:1553–1564.
   PubMed Web of Science ®Google Scholar
• Jayasinghe SA, Langen R. Identifying structural features of fibrillar islet amyloid polypeptide using site-directed spin labeling. J Biol Chem 2004;279:48420–48425.
   PubMed Web of Science ®Google Scholar
• Hohmeier HE, Mulder H, Chen G, Henkel-Rieger R, Prentki M, Newgard CB. Isolation of INS-1-derived cell lines with robust ATP-sensitive K + channel-dependent and -independent glucose-stimulated insulin secretion. Diabetes 2000;49:424–430.
   PubMed Web of Science ®Google Scholar
• Butler AE, Jang J, Gurlo T, Carty MD, Soeller WC, Butler PC. Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes. Diabetes 2004;53: 1509–1516.
   PubMed Web of Science ®Google Scholar
• Chen M, Margittai M, Chen J, Langen R. Investigation of α-synuclein fibril structure by site-directed spin labeling. J Biol Chem 2007;282:24970–24979.
   PubMed Web of Science ®Google Scholar
• Der-Sarkissian A, Jao CC, Chen J, Langen R. Structural organization of α-synuclein fibrils studied by site-directed spin labeling. J Biol Chem 2003;278:37530–37535.
   PubMed Web of Science ®Google Scholar
• Margittai M, Langen R. Template-assisted filament growth by parallel stacking of tau. Proc Natl Acad Sci USA 2004;101:10278–10283.
   PubMed Web of Science ®Google Scholar
• Torok M, Milton S, Kayed R, Wu P, McIntire T, Glabe CG, Langen R. Structural and dynamic features of Alzheimer's Abeta peptide in amyloid fibrils studied by site-directed spin labeling. J Biol Chem 2002;277:40810–40815.
   PubMed Web of Science ®Google Scholar
• Kudva YC, Mueske C, Butler PC, Eberhardt NL. A novel assay in vitro of human islet amyloid polypeptide amyloidogenesis and effects of insulin secretory vesicle peptides on amyloid formation. Biochem J 1998;331 (Part 3):809–813.
   PubMed Web of Science ®Google Scholar
• Naiki H Higuchi K, Hosokawa M, Takeda T. Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 1989;177:244–249.
   PubMed Web of Science ®Google Scholar
• Meng F, Marek P, Potter KJ, Verchere CB, Raleigh DP. Rifampicin does not prevent amyloid fibril formation by human islet amyloid polypeptide but does inhibit fibril Thioflavin-T interactions: implications for mechanistic studies of β-cell Death. Biochemistry 2008;47:6016–6024.
   PubMed Web of Science ®Google Scholar
• Lin CY, Gurlo T, Kayed R, Butler AE, Haataja L, Glabe CG, Butler PC. Toxic human islet amyloid polypeptide (h-IAPP) oligomers are intracellular, and vaccination to induce anti-toxic oligomer antibodies does not prevent h-IAPP-induced β-cell apoptosis in h-IAPP transgenic mice. Diabetes 2007;56:1324–1332.
   PubMed Web of Science ®Google Scholar
• Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999;48:491–498.
   PubMed Web of Science ®Google Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007;4:807–818.
   PubMed Web of Science ®Google Scholar